Plain-English translation of NCT06733077 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing two new digital devices — MachineMD and gaitQ — to see if they can help diagnose Parkinson's disease more accurately and track disease progression. Rather than relying on a doctor's observations during a clinic visit, these tools use technology to measure eye movements and walking patterns objectively. The research team wants to understand whether these digital tools could give doctors better, more detailed information to help diagnose Parkinson's earlier and provide more personalized care.
Currently, Parkinson's diagnosis depends heavily on what patients remember about their symptoms and how a neurologist observes them during an exam — which can be unreliable and subjective. This medication cannot measure small changes in the disease over time or catch early warning signs. The study aims to create objective, data-based diagnostic tools that are more precise and could help doctors catch Parkinson's sooner, when treatment may be most effective.
You likely qualify if…
You likely don't qualify if…
If you enroll, you would visit the research center to use the two digital devices. You would complete eye-tracking assessments (using MachineMD) and walking tests (using gaitQ) that measure how your eyes move and how you walk. These assessments take snapshots of your movement patterns and provide objective data that doctors could use to diagnose or monitor Parkinson's. The study is designed to test whether these tools are practical and useful, so your feedback will help shape how they develop these digital services for patients.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United Kingdom